AllNewsPhotosVideos
Biocon

Biocon Limited

Biocon limited, Latest News

Biocon Limited is an Indian biopharmaceutical company based in Bangalore, India. The Company manufactures generic active pharmaceutical ingredients that are sold in over 120 countries [no proof provided] across the globe, including the developed markets of the United States and Europe.
Read More
Integrated cell-cum-gene therapy facility unveiled in B'luru - Hindi News | Integrated cell-cum-gene therapy facility unveiled in B'luru | Latest health News at Lokmattimes.com

Health :Integrated cell-cum-gene therapy facility unveiled in B'luru

Bengaluru, Jan 18 Immuneel Therapeutics Ltd, co-founded by Biocon chairperson Kiran Mazumdar-Shaw, unveiled its integrated cell-and-gene therapy development ... ...

Kiran Mazumdar-Shaw new vice-chair of US-India biz body - Hindi News | Kiran Mazumdar-Shaw new vice-chair of US-India biz body | Latest business News at Lokmattimes.com

Business :Kiran Mazumdar-Shaw new vice-chair of US-India biz body

Washington/Bengaluru, Jan 14 Biocon Chairperson Kiran Mazumdar-Shaw is the new vice-chair of the US-India Business Council (USIBC) board ... ...

Andhra, Biocon join forces to establish skill colleges - Hindi News | Andhra, Biocon join forces to establish skill colleges | Latest politics News at Lokmattimes.com

Politics :Andhra, Biocon join forces to establish skill colleges

Amaravati, Sep 17 Andhra Pradesh State Skill Development Corporation (APSSDC) and biotech major Biocon have joined forces to ... ...

Biocon chief Kiran Mazumdar-Shaw tests Covid-19 positive - Hindi News | Biocon chief Kiran Mazumdar-Shaw tests Covid-19 positive | Latest health News at Lokmattimes.com

Health :Biocon chief Kiran Mazumdar-Shaw tests Covid-19 positive

Bengaluru, Aug 18 Biocon chairperson Kiran Mazumdar-Shaw on Monday night said she tested Covid-19 positive. "I have added ... ...

Tata Capital to pick minority stake in Biocon Biologics for Rs 225 cr - Hindi News | Tata Capital to pick minority stake in Biocon Biologics for Rs 225 cr | Latest business News at Lokmattimes.com

Business :Tata Capital to pick minority stake in Biocon Biologics for Rs 225 cr

Private equity major Tata Capital Growth Fund will pick up 0.85 per cent stake in the biologics arm of biopharmaceutical major Biocon for Rs 225 crore. ...

Use Itolizumab for moderate to severe COVID-19 patients: DCGI - Hindi News | Use Itolizumab for moderate to severe COVID-19 patients: DCGI | Latest national News at Lokmattimes.com

National :Use Itolizumab for moderate to severe COVID-19 patients: DCGI

New Delhi, July 11 The Drugs Controller General of India (DCGI) has okayed the use of Itolizumab (rDNA ... ...

Biocon's drug Itolizumab gets DCGI nod for use in moderate to severe Covid-19 patients - Hindi News | Biocon's drug Itolizumab gets DCGI nod for use in moderate to severe Covid-19 patients | Latest business News at Lokmattimes.com

Business :Biocon's drug Itolizumab gets DCGI nod for use in moderate to severe Covid-19 patients

Biopharmaceutical major Biocon Ltd said on Saturday it has received approval from the Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5ml solution for emergency use in India for the treatment of cytokine release syndrome ...

Karnataka mulls relief for MSMEs to revive growth - Hindi News | Karnataka mulls relief for MSMEs to revive growth | Latest business News at Lokmattimes.com

Business :Karnataka mulls relief for MSMEs to revive growth

The Karnataka government is mulling a relief package for micro, small and medium enterprises (MSMEs) to help revive growth in the state struck by Covid pandemic, state Large and Medium Scale Industries Minister Jagdish Shettar said on Tuesday. ...